UNSPSC 51122900: Antiarrythmic alkaline earth metals

This classification denotes based in part or whole on metals that constitute the group 2 of the periodic table (barium, beryllium, calcium, magnesium, radium, and strontium), substances called alkaline earth metals, that prevent or treat irregular heartbeat, disturbances of normal rhythmic heart beating, or normal operation of myocardial contraction, thus the term ANTIARRYTHMIC ALKALINE EARTH METALS.

UNSPSC 51122900 Antiarrhythmic alkaline earth metals is a Class code under which state and local governments procure cardiac and emergency-response medications—specifically intravenous antiarrhythmic drugs and related advanced life support injectables for fire rescue, emergency medical services, and health agency pharmacy benefit programs. The work encompasses supply of branded and generic formulations in unit-dose vial and injection formats, with strict shelf-life and expiration-date requirements, and includes compliance with FDA manufacturing standards, OSHA hazard communication protocols, and drug supply chain security regulations. Issuing bodies span city fire departments and rescue services (Tampa Fire Rescue), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving both state and local government facilities across multiple states including Oregon). The purchasing patterns show a mix of direct municipal procurement and state-level or cooperative-buying arrangements that serve broader networks of government end-users.

Recent activity is concentrated in the South and Upper Midwest. The City of Tampa issued an IFB (Bid No. 26P00188) due April 8, 2026, for Advanced Life Support Medications—370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials—with a one-year contract term and an estimated value of $40,000.00, featuring a 5 percent bid discount for Small Local Business Enterprise participation. The Texas Health and Human Services Commission issued RFI No. HHS0017013 (deadline April 3, 2026) to gather vendor capability information on direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers, with contract effectiveness July 1, 2026, requiring FDA compliance, cGMP certification, and Drug Supply Chain Security Act compliance, with a 3 percent administrative fee on all purchases.